FDA approves atezolizumab for stage II to IIIA lung cancer

October 15, 2021

Posted in FDA NewsTagged #inthenews

FDA approves mobocertinib for EGFR exon 20 insertion+ NSCLC

September 16, 2021

Posted in FDA News, ResearchTagged #fdaapprovals

Findings and developments in the lung cancer space during the first half of 2021

August 26, 2021

Posted in FDA News, Research

#TogetherSeparately Live Talk on recent FDA approvals

June 14, 2020

Posted in FDA News, Research

Approval of Keytruda Every Six Weeks a ‘Welcome Change’ for Patients With Cancer

May 31, 2020

Posted in FDA News, Research

FDA announcements speak to urgency of improving lung cancer treatment

May 12, 2020

Posted in FDA News, Research

2020 ASCO Annual Report highlights advancements in lung cancer treatment

February 12, 2020

Posted in FDA News, Research

New targeted therapy approved

August 16, 2019

Posted in FDA News, Research

FDA approves Pembrolizumab for second or third-line treatment of metastatic small cell lung cancer

July 2, 2019

Posted in FDA News

FDA Approves Pembrolizumab for First-Line Treatment of Stage III NSCLC

April 12, 2019

Posted in FDA News